St.Shine Optical Co.,Ltd. (TPEX:1565)
Taiwan
· Delayed Price · Currency is TWD 167.50
-1.00 (-0.59%)
Apr 24, 2025, 1:30 PM CST
St.Shine Optical Revenue
In the year 2024, St.Shine Optical had annual revenue of 4.55B TWD with 3.55% growth. St.Shine Optical had revenue of 1.23B in the quarter ending December 31, 2024, with 8.42% growth.
Revenue
4.55B
Revenue Growth
+3.55%
P/S Ratio
1.86
Revenue / Employee
1.23M
Employees
3,698
Market Cap
8.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.55B | 156.17M | 3.55% |
| Dec 31, 2023 | 4.39B | -609.61M | -12.18% |
| Dec 31, 2022 | 5.00B | -398.11M | -7.37% |
| Dec 31, 2021 | 5.40B | 395.02M | 7.89% |
| Dec 31, 2020 | 5.01B | -1.34B | -21.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Polaris Group | 107.00M |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |